We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medsea Estates | LSE:MEA | London | Ordinary Share | GB00B01TVW49 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.175 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCRV
RNS Number : 4074E
Craven House Capital PLC
04 November 2015
4 November 2015
Craven House Capital plc ("Craven House" or the "Company")
Craven House Capital and GEM Global Yield Fund Sign Stock Purchase Agreement valued at up to GBP30 million
Craven House Capital (AIM:CRV) is pleased to announce that it has entered into a stock purchase agreement with GEM Global Yield Fund, a member of the New York based Global Emerging Markets Group ("GEM"). Under the terms of the facility GEM will fund Craven House with up to GBP30 million through a structured stock subscription agreement. Under the terms of the agreement, funds are provided from GEM, with limited restrictions, at Craven House Capital's discretion through the issuance of new Ordinary shares in Craven House. The facility is designed to provide equity capital on an as-needed basis in support of future transactions and to provide additional capital to existing portfolio companies.
Craven House Chairman, Mark Pajak, explained, "This agreement provides Craven House with significant permanent capital to support future acquisitions. Having fresh capital available will speed the rate at which Craven House can continue to build value for shareholders over the long term. As with all previous issuances of new Ordinary shares, we do not envisage issuing new shares below 1.25 pence per share. We now have a strong financing partner in GEM. We look forward to working with them in seeking transformational acquisitions for the Company and are currently evaluating a number of opportunities; there are no guarantees that any of these will be completed, but further announcements will be made as appropriate."
Ends
For further information please contact:
Craven House Capital Plc Tel: 07590 831 323 Alexandra Eavis Non-Executive Director and Company Secretary www.Cravenhousecapital.com SPARK Advisory Partners Tel: 0203 368 3550 Limited Nominated Adviser Matt Davis/Mark Brady www.Sparkadvisorypartners.com
About Craven House Capital
Craven House Capital (AIM:CRV) is an investment company seeking deep value opportunities across the globe. It seeks to create long-term shareholder value on a per share basis by deploying patient capital. Craven House seeks to acquire real assets and operating companies that capable of generating steady cash flows.
About GEM Group
The Global Emerging Markets Group, www.gemny.com, is a $3.4 BN alternative investment group having completed 365 transactions in 65 countries. The firm manages a diverse set of investment vehicles across the world. GEM's funds include: CITIC/GEM Fund; Kinderhook Industries; GEM Global Yield Fund; and GEM India.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBJBJTMBIMBLA
(END) Dow Jones Newswires
November 04, 2015 02:00 ET (07:00 GMT)
1 Year Medsea Estates Chart |
1 Month Medsea Estates Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions